SUPPLY AGREEMENTSupply Agreement • November 3rd, 2015 • BioCancell Ltd. • Pharmaceutical preparations
POLYPLUS-TRANSFECTI ON SA, a company organized under the laws of France (“Polyplus”), having its place of business at Bioparc, Boulevard Sebastien Brant, 67401 Illkirch (France) hereinafter referred to as “SELLER” or “Seller”
BI Contract No. 100704 CLINICAL SUPPLY AGREEMENTClinical Supply Agreement • November 3rd, 2015 • BioCancell Ltd. • Pharmaceutical preparations • New York
WHEREAS, BioCancell’s Affiliated Company BioCancell Ltd. and BI RCV entered into a secrecy agreement (“CDA”) dated as of November 16, 2006, a material transfer agreement (“MTA”) dated as of April 3, 2013 and a Quality Agreement (“QA”) dated as of September 12, 2013; and
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 3rd, 2015 • BioCancell Ltd. • Pharmaceutical preparations
THIS AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made in Jerusalem as of this _ day of November 14, 2005 (the “Effective Date”).
